Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

NCT00017095 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1856

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: filgrastim
DRUG: cyclophosphamide
DRUG: docetaxel
DRUG: epirubicin hydrochloride
DRUG: fluorouracil
GENETIC: microarray analysis
OTHER: immunohistochemistry staining method
OTHER: laboratory biomarker analysis
PROCEDURE: biopsy
PROCEDURE: conventional surgery
PROCEDURE: neoadjuvant therapy
RADIATION: radiation therapy

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]
[object Object]
[object Object]